OTLK US Equity
Outlook Therapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1649989 · FY ends Sep 30$0.69
-0.01 (-1.41%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 20.0M |
| % of shares out | 8.2% |
| Days to cover | 1.1 |
| Δ vs 2026-07-15 | +78.0% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 20,013,892 | +78.0% | 18,337,663 | 1.1 |
| 2026-07-15 | 11,240,969 | -19.8% | 9,099,076 | 1.2 |
| 2026-06-30 | 14,014,673 | +3.2% | 15,859,040 | 1.0 |
| 2026-06-15 | 13,576,714 | -15.8% | 21,412,461 | 1.0 |
| 2026-05-29 | 16,133,268 | +77.5% | 65,462,641 | 1.0 |
| 2026-05-15 | 9,088,387 | +41.3% | 4,150,596 | 2.2 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
